Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma ... - UroToday PDF Print
UroTodaySunitinib is approved for treatment of advanced renal cell carcinoma (rcc). Based on a clinical observation that patients receiving sunitinib developed

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.